Record #46643
Efficacy, Safety, and Tumor Marker Inhibition of Apatinib Combined with Conventional Chemotherapy Regimens for Patients with Advanced Triple-Negative Breast Cancer
Publisher
Original paper date
Oct 13, 2021
Original DOI
Country
Open access
No
Article type
Notes from Retraction Watch
See also: https://pubpeer.com/publications/9762F9011D67577D13017160CFFFCD
Citation lifecycle
How this paper is being cited
Pre-retraction
3
Same day
1
Post-retraction
3
% post-retraction
42.9%
~1.8 citations/yr before retraction · ~0.9 citations/yr after
— citing papers
Who is still citing this work
Loading…